Navigation Links
Jiangbo Pharmaceuticals Reaffirms Guidance for Fiscal 2009
Date:9/8/2009

LAIYANG, China, Sept. 8 /PRNewswire-Asia-FirstCall/ -- Jiangbo Pharmaceuticals, Inc. (OTC Bulletin Board: JGBO) (the "Company", "Jiangbo"), a U.S. pharmaceutical company with its principal operations in the People's Republic of China, today reaffirmed its previously announced guidance for fiscal year 2009. The Company expects to meet or exceed its goals of $111 to $116 million in revenue and operating income of $40 to $43 million for the fiscal year ending June 30, 2009.

"We plan to report our annual results for the fiscal year 2009 by the end of this month and are pleased to reaffirm we are on track to achieve our financial goals," said Mr. Wubo Cao, Chief Executive Officer of Jiangbo. "We continue to revamp the production lines which we acquired from Hongrui earlier this year. We expect this project to be completed in May 2010, when we should be able to begin mass production of other profitable TCM products. Thus, we continue to feel confident in maintaining a healthy growth rate over the long term."

About Jiangbo Pharmaceuticals, Inc.

Jiangbo Pharmaceuticals, Inc. is a U.S. public company engaged in the research, development, production, marketing and sales of pharmaceutical products in the People's Republic of China. Its operations are located in Eastern China in an Economic Development Zone in Laiyang City, Shandong province. Jiangbo is a major pharmaceutical company in China producing both western and Chinese herbal-based medical drugs in tablet, capsule, granule, syrup and electuary (sticky syrup) form. http://www.jiangbopharma.com

Safe Harbor Statement

Certain statements in this press release that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of fu
'/>"/>

SOURCE Jiangbo Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Jiangbo Pharmaceuticals to Present at Rodman & Renshaw Annual Global Investment Conference
2. Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
3. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
4. Amylin Pharmaceuticals to Present at Morgan Stanley Global Healthcare Unplugged Conference
5. Adamas Pharmaceuticals to Present Data on Triple Combination Antiviral Drug Therapy for Drug-Resistant Influenza at 2009 ICAAC Annual Meeting
6. Oramed Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference
7. NovaBay(R) Pharmaceuticals to Present at Rodman & Renshaw 11th Annual Healthcare Conference September 10, 2009 in New York City
8. Optimer Pharmaceuticals to Present at September 2009 Investor Conferences
9. Arena Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference
10. OncoGenex Pharmaceuticals to Webcast Presentations at September Investor Conferences
11. Onyx Pharmaceuticals to Present at Two Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)...  U.S. Secretary of State John Kerry ... Syngenta  scientist Mary-Dell Chilton , Ph.D., was named ... The prize is the foremost international award recognizing individuals ... quantity or availability of food in the world. ... for "revolutionary biotechnology discoveries that unlocked the key to ...
(Date:6/19/2013)...  Continuing its long history of proven clinical performance ... , Inc. announces the U.S. Food and Drug Administration ... I assay for use on its Access 2 immunoassay ... Beckman Coulter,s troponin I test for over 12 ... performance to continue providing dependability to laboratories supporting emergency ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
(Date:6/19/2013)... June 19, 2013 Express Diagnostics Int’l, ... today announced that it has received Class III medical ... sell its DrugCheck® NxStep Onsite Drug Screen Cup ... the rapid screening device in near-patient settings, such as ... Cup received Health Canada Class III approval for 24 ...
Breaking Biology Technology:Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... companies tied for the top prize at the first-annual ... close of the Entrepreneurs Conference Wednesday evening in Milwaukee, ... first and second place, or $55,000. , ,Other category ... IntelliMentor. , ,The quality of the business plans was ...
... MILWAUKEE The Wisconsin Entrepreneurs Conference ... flourish in a competitive market, with a seminar ... market potential of ideas. Entrepreneurs and industry representatives ... shared strategies for making a product survive and ...
... MADISON Be honest: Everything you know about nanotechnology is ... meets the super-model, and within the space of about 30 ... nerdy baby wearing eyeglasses. , ,Dont feel left out, however, ... backyard grill. The field of nanotechnology is so new that ...
Cached Biology Technology:Governors business-plan contest has a surprise ending 2Governors business-plan contest has a surprise ending 3Governors business-plan contest has a surprise ending 4Governors business-plan contest has a surprise ending 5Governors business-plan contest has a surprise ending 6Entrepreneurs learn to assess potential ideas 2Entrepreneurs learn to assess potential ideas 3Small wonders: Intersection of biotech and nanotech will produce big advances 2Small wonders: Intersection of biotech and nanotech will produce big advances 3
(Date:6/19/2013)... 19, 2013 Elsevier, a world-leading provider of scientific, ... to announce the launch of a new open access ... of GeoResJ , Elsevier,s earth and planetary science ... The journal aims to provide a forum for rapid ... field. The journal will be co-edited by six Executive ...
(Date:6/18/2013)... awarded a $394,300 grant from the Tarrant Regional ... in the new facilities of the 150-mile Integrated ... professor of civil engineering, will investigate the best ... water in an effort to eliminate biological growths ... monochloramine is widely practiced throughout the United States. ...
(Date:6/18/2013)... National Institutes of Health has awarded $12.7 million ... selection of pharmaceutical industry compounds to explore new ... Alzheimer,s disease, Duchenne muscular dystrophy and schizophrenia. The ... for Existing Molecules, is led by the National ... by the NIH Common Fund. , The process ...
Breaking Biology News(10 mins):UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2NIH to fund collaborations with industry to identify new uses for existing compounds 2NIH to fund collaborations with industry to identify new uses for existing compounds 3NIH to fund collaborations with industry to identify new uses for existing compounds 4
... and their colleagues at other research centers have found a ... the impact of the aging process. Their study, which will ... lends more credence to the free-radical theory of aging. , ... can be damaging to the body at the cellular level. ...
... Results showed that the microbes in about a half a ... the rumen, the largest chamber of a cow's stomach - ... voltage needed to run one rechargeable AA-sized battery, said Ann ... agricultural and biological engineering at Ohio State University. , While ...
... brain develops, neurons reach out helter-skelter forming new connections, ... the brain chooses which connections to keep and which ... branches have the most electrical activity—a finding that could ... , The work, published in the April 21 issue ...
Cached Biology News:Researchers extend mouse lifespan by protecting against free radicals 2Researchers extend mouse lifespan by protecting against free radicals 3It's electric: Cows show promise as powerplants 2It's electric: Cows show promise as powerplants 3Speak up: Louder neurons form more connections 2
Integrins Sampler Kit 10g each...
Protein Tyrosine Phosphatase Sampler Kit 10g each...
... Solid phase reagent for ... Easy & unique water ... with detergents and chaotropes; ... recover non-envelop viruses while ...
Caveolin Sampler Kit 10g each...
Biology Products: